Oral Answers to Questions Debate

Full Debate: Read Full Debate
Department: Scotland Office

Oral Answers to Questions

Stephen Hammond Excerpts
Wednesday 13th September 2023

(1 year, 3 months ago)

Commons Chamber
Read Full debate Read Hansard Text Watch Debate Read Debate Ministerial Extracts
Rishi Sunak Portrait The Prime Minister
- View Speech - Hansard - - - Excerpts

Of course I am sorry for the disruption at schools as we work hard to identify those affected, but the DFE is fully funding the inspection process, ensuring that we are now rapidly inspecting and surveying all potentially affected schools and paying for that work. Also, with the increase of up to 80 dedicated caseworkers, St James’s Primary School, like others, should have a dedicated point of contact to work through those issues. I will ensure that the Secretary of State and the Department are in touch with the school and the hon. Member for an update.

Stephen Hammond Portrait Stephen Hammond (Wimbledon) (Con)
- View Speech - Hansard - -

Q9.   Personally, I know the stark impact of dementia and the effect that it has on the families of our 1 million citizens who live with it. It was my honour last week to sponsor Alzheimer’s Research UK to highlight the recent progress on a new diagnostic test and new drugs that could be available as early as next January. I welcome the inclusion of dementia in the Government’s major conditions strategy, but will my right hon. Friend ask his Secretary of State to convene a dementia medicines taskforce so that we can take advantage of this progress in research? Will he consider Alzheimer’s Research UK’s request for a dementia champion?

Rishi Sunak Portrait The Prime Minister
- View Speech - Hansard - - - Excerpts

I start by thanking my hon. Friend for his work in this important area. Regulators are working closely with industry to evaluate new dementia medicines, because of course we want patients to benefit from rapid access to safe and effective treatments. We are also strongly committed to funding dementia research, including doubling the amount allocated to £160 million a year by next year, and last year we launched the Dame Barbara Windsor dementia mission, backed up with new funding, which will work with industry to develop biomarkers and data and digital science innovations and to strengthen our trials in dementia. I look forward to hearing more suggestions from my hon. Friend on that.